Yes—enlicitide, a cholesterol-lowering pill, lowered LDL Cholesterol by about 56% compared with a pill containing no active drug. The report combined three studies of adults with high cholesterol despite standard treatment. Some had an inherited form of high cholesterol. People were assigned by chance to enlicitide or an inactive pill. Enlicitide belongs to PCSK9 Inhibitors, medicines that help the liver clear cholesterol from the blood. This report focused on a pill, rather than injections. The largest study included 2,909 people across 14 countries. It tested 20 milligrams daily for 52 weeks. Another study tested four doses in 381 people over eight weeks. The third study included 303 people. Across six comparisons, the average drop in LDL Cholesterol was 56.19% greater than with the inactive pill. The estimated reduction ranged from about 48% to 64%, allowing for uncertainty. Results varied across studies, but no single study group drove the overall finding. That is a group average, not a promise for each person. The supplied report does not give side-effect results or show whether heart attacks fell. It also does not compare the pill directly with injections. For BioSocial members, this offers context for tracking changes in bloodwork over time. Starting levels, dose, other medicines, and time between tests matter when comparing notes. Sharing those details alongside before-and-after numbers can make community discussions more useful. A large percentage drop tells only part of someone’s story. What changes have you seen in your own cholesterol numbers, and over what time frame?